We can always find examples supporting our views, Sox. I don't think we should be comparing IPIX to Pharmacyclics just yet. Haha. And in isolation it wouldn't necessarily be a red flag. When you throw in the delays and misrepresenting of Prurisol, shelving 1 drug and another drugs P3, a promised up list etc. you have a red flag.
Market Data 
Markets 
AI
